MED1 and head and neck squamous cell carcinoma: The findings revealed a notable upregulation of MED1 expression in individuals diagnosed with head and neck squamous cell carcinomas (HNSC) (Fig. 1A), a result further corroborated by data from the TIMER databases (Fig. 1B).